Pioneering UK biotechnology business, Fixed Phage, has secured additional investment to scale up its fight against new microbial threats that pose risks to human health and agricultural production. The company, based in Glasgow, has developed an innovative, cost-effective technology that makes bacteriophages – natural antimicrobials – able to eliminate problem bacteria. The patented solution has…
About Fixed Phage
Fixed Phage is a biotechnology company developing and commercialising unique, proprietary, anti-infective technologies based on bacteriophage immobilisation and stabilisation. It is developing a well-proven and comprehensively patented surface modification technology, that irreversibly attaches and stabilises bacteriophage on a wide range of carrier materials, thereby creating biologically active interventions.
Pippa Moraitopoulos, Garnett Keeler PR+44 (0)20 8647 4467
Lucy Pitcher, Garnett Keeler PR+44 (0)20 8647 4467
You'll need an RSS reader to view our feed